Hydrochloric Acid

Hydrochloric Acid

SCHEMBL456275

C1CNCN1.Cl

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL27333994 1.00
Hydrochloric Acid SCHEMBL28627688 1.00
Hydrochloric Acid SCHEMBL27962955 0.95
SCHEMBL9614403 0.94 HIF1A (0.56)
SCHEMBL26047 0.94
Methane SCHEMBL18191054 0.89 HIF1A (0.50)
Iodide SCHEMBL19272496 0.89
SCHEMBL13671434 0.89 HIF1A (0.67)
Piperazine SCHEMBL22158351 0.89 HIF1A (0.67)
SCHEMBL4273750 0.89

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119859216-A Polar functionalized conjugated diene polymer and preparation method thereof 东华大学 2025-04-22 CN claimed
CN-109320559-B Nickel-palladium metal complex, preparation method and application thereof, product and application thereof 东华大学 2020-10-30 CN claimed
EP-2178943-A1 METHOD FOR THE PRODUCTION OF THIOPHENE OLIGOMERS Bayer Technology Services GmbH (DE) 2010-04-28 EP claimed
EP-2176314-A2 PROCESS FOR THE PREPARATION OF POLY- AND OLIGOTHIOPHENES ON AN INDUSTRIAL SCALE Bayer Technology Services GmbH (DE) 2010-04-21 EP claimed
EP-2167565-A1 PROCESS FOR SYNTHESIZING OLIGO/POLYTHIOPHENES BY A 'ONE-POT' SYNTHESIS ROUTE Bayer Technology Services GmbH (DE) 2010-03-31 EP claimed
WO-2009021639-A1 METHOD FOR THE PRODUCTION OF THIOPHENE OLIGOMERS BAYER TECHNOLOGY SERVICES GMBH (DE) 2009-02-19 WO claimed
WO-2009015810-A2 PROCESS FOR THE PREPARATION OF POLY- AND OLIGOTHIOPHENES ON AN INDUSTRIAL SCALE BAYER TECHNOLOGY SERVICES GMBH (DE) 2009-02-05 WO claimed
WO-2009007012-A1 PROCESS FOR SYNTHESIZING OLIGO/POLYTHIOPHENES BY A 'ONE-POT' SYNTHESIS ROUTE BAYER TECHNOLOGY SERVICES GMBH (DE) 2009-01-15 WO claimed
CN-119859216-A Polar functionalized conjugated diene polymer and preparation method thereof 东华大学 2025-04-22 CN disclosed
US-20250019565-A1 POLYCYCLOCARBONATE COMPOUNDS AND POLYMERS AND COMPOSITIONS FORMED THEREFROM SWIMC LLC (US) 2025-01-16 US disclosed
US-12077676-B2 Polycyclocarbonate compounds and polymers and compositions formed therefrom SWIMC LLC (US) 2024-09-03 US disclosed
CN-112135830-B Oxo-substituted compounds 住友制药株式会社 2024-06-14 CN disclosed
US-11746096-B2 Polycyclocarbonate compounds and polymers formed therefrom SWIMC LLC (US) 2023-09-05 US disclosed
CN-109320559-B Nickel-palladium metal complex, preparation method and application thereof, product and application thereof 东华大学 2020-10-30 CN disclosed
CN-1046501-C Novel thiourea complexes and process for preparing nitroarylimino heterocycles ALCON LAB INC (US) 1999-11-17 CN disclosed
CN-1220261-A Novel process for preparation of clonidine derivatives ALCON LAB INC (US) 1999-06-23 CN disclosed
CN-1123026-A Novel process for preparing clonidine derivatives ALCON LAB INC (US) 1996-05-22 CN disclosed
EP-0178581-B1 Use of 2-[(2-bromo-6-fluorophenyl)imino]imidazolidine as a sedative BOEHRINGER INGELHEIM VETMEDICA GMBH (DE) 1992-01-22 EP disclosed
US-4624960-A 2-112-BROMO-6-FLUOROPHENYLIMINOIMIDAZOLIDINE BOEHRINGER INGELHEIM VETMEDICA GMBH (DE) 1986-11-25 US disclosed
EP-0178581-A2 Use of 2-[(2-bromo-6-fluorophenyl)imino]imidazolidine as a sedative BOEHRINGER INGELHEIM VETMEDICA GMBH (DE) 1986-04-23 EP disclosed